Ensign Peak Advisors, Inc Kala Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.62 - $5.43 $120,758 - $250,274	-46,091 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.06 - $8.15 $375,123 - $604,200	-74,135 Reduced 61.66%	46,091 $244,000
Q4 2020 Feb 12, 2021	SELL	$6.28 - $8.79 $122,698 - $171,739	-19,538 Reduced 13.98%	120,226 $815,000
Q3 2020 Nov 12, 2020	SELL	$7.5 - $11.11 $1.39 Million - $2.06 Million	-185,181 Reduced 56.99%	139,764 $1.05 Million
Q2 2020 Aug 12, 2020	BUY	$8.33 - $13.79 $839,688 - $1.39 Million	100,803 Added 44.97%	324,945 $3.42 Million

Q1 2020 May 11, 2020	BUY	$3.83 - $8.79 $858,463 - $1.97 Million	224,142 New	224,142 $1.97 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.